A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.
Clinical trial NCT05689164 · TERMINATED
Trial details
- NCT number
- NCT05689164
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2025-09-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.